Please login to the form below

Not currently logged in
Email:
Password:

Therapy Area

This page shows the latest Therapy Area news and features for those working in and with pharma, biotech and healthcare.

FDA sets June decision date for Tecentriq monotherapy in NSCLC

FDA sets June decision date for Tecentriq monotherapy in NSCLC

The triple regimen was also approved by the European Commission as a second-line treatment after targeted therapy for patients whose tumours are EGFR mutated or ALK-positive. ... However, the NSCLC therapy area is dominated by Merck’s rival PD-1

Latest news

More from news
Approximately 0 fully matching, plus 247 partially matching documents found.

Latest Intelligence

  • Understanding the patient journey Understanding the patient journey

    By investigating the current landscape that patients face in a particular therapy area, and how they are using existing services supplied by competitors, you can understand what the shortfalls or gaps

  • Breaking from tradition - social media at medical congresses Breaking from tradition - social media at medical congresses

    chosen therapy area (see, for example, hashtags such as #meded, #foamed and #hcsm). ... Consider the role of partners, whether Digital Opinion Leaders (those HCPs who are actively influencing the conversation within a therapy area), research organisations

  • The handover: Pfizer reshapes itself for a new era The handover: Pfizer reshapes itself for a new era

    The therapy area is dominated by Merck’s Keytruda, BMS’ Opdivo and Roche’s Tecentriq, but Pfizer is hoping that combinations such as its own Inlyta and Bavencio can help it ... It has gene therapy deals with Spark in haemophilia and with Sangamo in

  • Trust me, I’m from pharma Trust me, I’m from pharma

    The pioneering companies are those who are not focused simply on selling their drugs – they are committed to a therapy area, committed to the experts and, fundamentally, committed to the patients.

  • Developing advocacy in the pharmaceutical industry Developing advocacy in the pharmaceutical industry

    But if you or your company is new to a therapy area, you may wish to use KOL profiling or mapping to help identify the right candidates.

More from intelligence
Approximately 0 fully matching, plus 48 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 14 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 79 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Purple Agency

An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....

Latest intelligence

The ALS patient journey
Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
Equipping your medical affairs teams with solutions to navigate the healthcare landscape
Dr Tyler Ray, OPEN Health Medical Communications...
Protein degraders
Can protein degraders unlock ‘undruggable’ drug targets?
Exploring a new and exciting area of small-molecule drug discovery...

Infographics